Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vsee Health (VSEE) Income towards Parent Company (2023 - 2025)

Vsee Health filings provide 3 years of Income towards Parent Company readings, the most recent being -$7.8 million for Q4 2025.

  • On a quarterly basis, Income towards Parent Company fell 59.56% to -$7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$14.7 million, a 75.03% increase, with the full-year FY2025 number at -$14.7 million, up 75.31% from a year prior.
  • Income towards Parent Company hit -$7.8 million in Q4 2025 for Vsee Health, down from -$289745.0 in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $94750.0 in Q1 2024 to a low of -$53.9 million in Q3 2024.
  • Median Income towards Parent Company over the past 3 years was -$2.5 million (2023), compared with a mean of -$7.0 million.
  • The widest YoY moves for Income towards Parent Company: up 113.2% in 2024, down 30314.72% in 2024.
  • Vsee Health's Income towards Parent Company stood at -$2.5 million in 2023, then crashed by 95.02% to -$4.9 million in 2024, then plummeted by 59.56% to -$7.8 million in 2025.
  • The last three reported values for Income towards Parent Company were -$7.8 million (Q4 2025), -$289745.0 (Q3 2025), and -$2.6 million (Q2 2025) per Business Quant data.